Correspondence 0001628280-24-015319 from LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc.
Date: April 8, 2024 · CIK: 0001815776 · Accession: 0001628280-24-015319
AI Filing Summary & Sentiment
File numbers found in text: 333-278393
Letter
Document
April 8, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Chris Edwards
Re: LENZ Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-278393
Acceleration Request
Requested Date: April 10, 2024
Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, LENZ Therapeutics, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-1 (File No. 333-278393) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Ben Capps at (858) 350-2237.
Sincerely,
LENZ THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Document April 8, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Chris Edwards Re: LENZ Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-278393 Acceleration Request Requested Date: April 10, 2024 Requested Time: 4:00 p.m. Eastern Time, or as soon thereafter as practicable Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, LENZ Therapeutics, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-1 (File No. 333-278393) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Ben Capps at (858) 350-2237. Sincerely, LENZ THERAPEUTICS, INC. By: /s/ Evert Schimmelpennink Evert Schimmelpennink Chief Executive Officer cc: Daniel Chevallard, LENZ Therapeutics, Inc. Dan Koeppen, Wilson Sonsini Goodrich & Rosati Ben Capps, Wilson Sonsini Goodrich & Rosati